Alice Shaw, Global Head of Translational Clinical Oncology at Novartis, applies lessons from running clinical trials to the work of designing them.

Novartis researchers are searching for more effective ways to discover drugs for neurological and psychiatric diseases.

The race is on to find a new treatment before resistance to today’s drugs becomes widespread.

Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.

Meet Melanoma survivor TJ Sharpe in the first installment of his new blog series on Novartis.com.

Novartis is developing an experimental drug for weight loss.

Novartis researchers leverage in-house startup initiative to begin digital technology research collaboration.